Catalyst Pharmaceutical CPRX Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Catalyst Pharmaceutical’s reported figures.
Based on trailing twelve months.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's free cash flow margin?
- Catalyst Pharmaceutical (CPRX) reported free cash flow margin of 34.9% in Q1 2026.
- How has Catalyst Pharmaceutical's free cash flow margin changed year-over-year?
- Catalyst Pharmaceutical's free cash flow margin decreased by 30.3% year-over-year, from 50% to 34.9%.
- What is the long-term trend for Catalyst Pharmaceutical's free cash flow margin?
- Over 3 years (2021 to 2025), Catalyst Pharmaceutical's free cash flow margin has grown at a -5.6% compound annual growth rate (CAGR), from 42.1% to 35.4%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.